• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠肝转移切除术后切缘和 KRAS 状态对预后的影响。

The effects of resection margin and KRAS status on outcomes after resection of colorectal liver metastases.

机构信息

Department of Hepatobiliary and Pancreatic Surgery, Queen Elizabeth Hospital, Birmingham, B15 2WB, United Kingdom.

Institute of Translational Medicine, Queen Elizabeth Hospital, Birmingham, B15 2WB, United Kingdom.

出版信息

HPB (Oxford). 2021 Jan;23(1):90-98. doi: 10.1016/j.hpb.2020.04.016. Epub 2020 May 13.

DOI:10.1016/j.hpb.2020.04.016
PMID:32417170
Abstract

BACKGROUND

The aim of this study was to investigate the influence of resection margin status in patients with KRAS mutations (mt-KRAS) when compared to those with wild-type KRAS (wt-KRAS) on long-term outcomes in patients with resected CRLM.

METHODS

All patients who underwent resection of CRLM with curative intent between January 2011 and December 2016 and had a KRAS type recorded were included in the study. Overall survival (OS), as well as death-censored overall (RFS) and liver-specific (LS-RFS) recurrence-free survival between KRAS types and the margin status within KRAS subgroups were compared using Cox regression models.

RESULTS

Data were available for N = 500 patients (30.4% mt-KRAS). mt-KRAS status was independently associated with significantly shorter OS. Within the wt-KRAS subgroup, smaller margins were found to be associated with significantly shorter death-censored LS-RFS (p < 0.001), with HRs of 1.93 (p = 0.005) for 1-4 mm margins and 2.83 (p < 0.001) for <1 mm margins, relative to those with clear margins. No such association was observed in the mt-KRAS subgroup (p = 0.721).

CONCLUSION

The resection margin status is of greater importance in patients with wt-KRAS. Such information could be useful in the operative planning, especially for those with multiple metastatic deposits, and also in the post-operative counselling and surveillance based on the margin and KRAS status.

摘要

背景

本研究旨在探讨 KRAS 突变(mt-KRAS)患者与 KRAS 野生型(wt-KRAS)患者相比,在接受结直肠癌肝转移(CRLM)根治性切除术后长期结局方面,切缘状态的影响。

方法

本研究纳入了 2011 年 1 月至 2016 年 12 月期间接受 CRLM 根治性切除且 KRAS 类型记录完整的所有患者。采用 Cox 回归模型比较 KRAS 类型之间以及 KRAS 亚组内切缘状态之间的总生存(OS)、死亡风险校正总(RFS)和肝脏特异性(LS-RFS)无复发生存率。

结果

本研究共纳入 500 例患者(30.4%为 mt-KRAS)。mt-KRAS 状态与 OS 显著缩短独立相关。在 wt-KRAS 亚组中,较小的切缘与死亡风险校正 LS-RFS 显著缩短相关(p<0.001),1-4mm 切缘的 HR 为 1.93(p=0.005),<1mm 切缘的 HR 为 2.83(p<0.001),与切缘清晰的患者相比。在 mt-KRAS 亚组中未观察到这种相关性(p=0.721)。

结论

切缘状态在 wt-KRAS 患者中更为重要。这种信息在手术规划中可能有用,特别是对于那些有多发性转移灶的患者,并且也可以根据切缘和 KRAS 状态在术后咨询和监测中使用。

相似文献

1
The effects of resection margin and KRAS status on outcomes after resection of colorectal liver metastases.结直肠肝转移切除术后切缘和 KRAS 状态对预后的影响。
HPB (Oxford). 2021 Jan;23(1):90-98. doi: 10.1016/j.hpb.2020.04.016. Epub 2020 May 13.
2
Critical appraisal of surgical margins according to KRAS status in liver resection for colorectal liver metastases: Should surgical strategy be influenced by tumor biology?结直肠肝转移行肝切除术中根据 KRAS 状态进行手术切缘评估:肿瘤生物学是否应影响手术策略?
Surgery. 2024 Jul;176(1):124-133. doi: 10.1016/j.surg.2024.02.008. Epub 2024 Mar 21.
3
Effect of KRAS and BRAF Mutations on Survival of Metastatic Colorectal Cancer After Liver Resection: A Systematic Review and Meta-Analysis.KRAS 和 BRAF 基因突变对肝切除术后转移性结直肠癌患者生存的影响:系统评价和荟萃分析。
Clin Colorectal Cancer. 2017 Sep;16(3):e153-e163. doi: 10.1016/j.clcc.2017.01.004. Epub 2017 Jan 25.
4
Codon 13 KRAS mutation predicts patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.第 13 密码子 KRAS 突变可预测行肝切除术的结直肠癌肝转移患者的复发模式。
Cancer. 2016 Sep 1;122(17):2698-707. doi: 10.1002/cncr.30085. Epub 2016 May 31.
5
Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer.BRAF 突变与手术治疗转移性结直肠癌肝转移患者生存和复发的关系。
JAMA Surg. 2018 Jul 18;153(7):e180996. doi: 10.1001/jamasurg.2018.0996.
6
Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence.KRAS、BRAF、PI3K和TP53基因突变分析对可切除和不可切除结直肠癌肝转移的临床意义及预后相关性:当前证据的系统评价
Surg Oncol. 2018 Jun;27(2):280-288. doi: 10.1016/j.suronc.2018.05.012. Epub 2018 May 8.
7
KRAS Mutation Predicted More Mirometastases and Closer Resection Margins in Patients with Colorectal Cancer Liver Metastases.KRAS 突变预测结直肠癌肝转移患者存在更多的微小转移灶和更接近的切缘。
Ann Surg Oncol. 2020 Apr;27(4):1164-1173. doi: 10.1245/s10434-019-08065-5. Epub 2019 Nov 12.
8
Prognostic Implication of KRAS Status after Hepatectomy for Colorectal Liver Metastases Varies According to Primary Colorectal Tumor Location.结直肠癌肝转移肝切除术后KRAS状态的预后意义因原发性结直肠癌肿瘤位置而异。
Ann Surg Oncol. 2016 Oct;23(11):3736-3743. doi: 10.1245/s10434-016-5361-6. Epub 2016 Jun 28.
9
Prognosis of Synchronous Colorectal Liver Metastases After Simultaneous Curative-Intent Surgery According to Primary Tumor Location and KRAS Mutational Status.原发肿瘤部位和 KRAS 突变状态对同时性结直肠癌肝转移患者行根治性手术预后的影响
Ann Surg Oncol. 2020 Dec;27(13):5150-5158. doi: 10.1245/s10434-020-09041-0. Epub 2020 Aug 18.
10
The Prognostic Impact of KRAS Mutation in Patients Having Curative Resection of Synchronous Colorectal Liver Metastases.KRAS 基因突变对同步结直肠肝转移瘤根治性切除术后患者预后的影响。
J Gastrointest Surg. 2019 Oct;23(10):1957-1963. doi: 10.1007/s11605-018-3978-4. Epub 2018 Oct 1.

引用本文的文献

1
The Impact of KRAS Status on Long-Term Outcomes After Thermal Ablation and Hepatic Resection for Liver-Only Colorectal Metastases: A New Clue for Tailoring Surgical Strategy on Tumor Biology?KRAS状态对单纯性肝转移结直肠癌热消融和肝切除术后长期预后的影响:根据肿瘤生物学制定手术策略的新线索?
World J Surg. 2025 Jun;49(6):1573-1582. doi: 10.1002/wjs.12616. Epub 2025 May 8.
2
The Effect of Hepatic Surgical Margins of Colorectal Liver Metastases on Prognosis: A Systematic Review and Meta-Analysis.结直肠癌肝转移肝手术切缘对预后的影响:一项系统评价与Meta分析
J Clin Med. 2024 Dec 19;13(24):7776. doi: 10.3390/jcm13247776.
3
Challenges and Opportunities for Precision Surgery for Colorectal Liver Metastases.
结直肠癌肝转移精准手术面临的挑战与机遇
Cancers (Basel). 2024 Jun 28;16(13):2379. doi: 10.3390/cancers16132379.
4
ICG-Fluorescence Imaging for Margin Assessment During Minimally Invasive Colorectal Liver Metastasis Resection.吲哚菁绿荧光成像在微创结直肠癌肝转移切除术中评估切缘的应用。
JAMA Netw Open. 2024 Apr 1;7(4):e246548. doi: 10.1001/jamanetworkopen.2024.6548.
5
Is Precision Surgery Applicable to Colorectal Liver Metastases? A Systematic Review and Meta-analysis of Studies that Investigate the Association of Surgical Technique with Outcomes in the Context of Distinct Tumor Biology.精准手术是否适用于结直肠癌肝转移?一项系统评价和荟萃分析研究了手术技术与不同肿瘤生物学背景下结局之间的关联。
Ann Surg Oncol. 2024 Mar;31(3):1823-1832. doi: 10.1245/s10434-023-14774-9. Epub 2023 Dec 28.
6
Impact of Molecular Status on Metastasectomy of Colorectal Cancer Liver Metastases.分子状态对结直肠癌肝转移灶切除术的影响
Clin Colon Rectal Surg. 2023 Apr 9;36(6):423-429. doi: 10.1055/s-0043-1767700. eCollection 2023 Nov.
7
Precision Surgery of Colorectal Liver Metastases in the Current Era: A Systematic Review.当代结直肠癌肝转移的精准手术:一项系统评价
Cancers (Basel). 2023 Mar 31;15(7):2083. doi: 10.3390/cancers15072083.
8
The Impact of KRAS Status on the Required Surgical Margin Width for Colorectal Liver Metastasis Resection.KRAS状态对结直肠癌肝转移灶切除所需手术切缘宽度的影响
J Clin Med. 2023 Mar 16;12(6):2313. doi: 10.3390/jcm12062313.
9
The Role of Biomarkers in the Management of Colorectal Liver Metastases.生物标志物在结直肠癌肝转移管理中的作用
Cancers (Basel). 2022 Sep 22;14(19):4602. doi: 10.3390/cancers14194602.
10
Assessment Following ESMO Recommendations for Colorectal Liver Metastases. Is It Always Worth It?遵循欧洲肿瘤内科学会(ESMO)关于结直肠癌肝转移的建议进行评估。这总是值得的吗?
Healthcare (Basel). 2022 Mar 3;10(3):472. doi: 10.3390/healthcare10030472.